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Cancer	was	estimated	to	account	for	about	7	million	deaths	worldwide	and	about	10	mil-
lion	new	cases	in	2000	(1).	It	is	the	third	most	common	cause	of	death	in	the	world	after	
cardiovascular	and	infectious	diseases.	Cancer	is	also	estimated	to	be	responsible	for	6%	
of	the	global	burden	of	diseases	(2).	Approximately,	70%	of	all	cancer	deaths	occurred	
in	the	developing	countries	(3),	however,	ageing	of	the	population,	and	good	control	of	
communicable	diseases	substantially	increased	cancer-related	proportional	mortality	in	
the	developed	countries.	Moreover,	there	is	expected	further	increase	in	cancer	mortality	
by	about	70%	in	the	developing	and	about	30%	in	the	developed	countries	(4).
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Colorectal	 cancer	 in	 one	 of	 the	most	 common	 cancers	worldwide	 responsible	 for	
approximately	 579	 000	 deaths/year	 (8.4%	 of	 all	 cancers	 deaths),	 preceded	 only	 by	
1	213	000	 trachea,	bronchus	and	 lung	cancer-related	deaths	 (17.5%),	744	000	due	 to	
stomach	cancer	(10.7%),	and	626	000	due	to	liver	cancer	(9.0%)	(5).	The	numbers	of	
colorectal	cancer	deaths	vary	across	the	world	and	are	closely	related	to	the	level	of	de-
velopment	in	the	region.	Colorectal	cancer	mortality	and	morbidity	rates	are	about	5	to	
10-fold	higher	in	the	developed	than	in	the	developing	countries.	
In	 Poland,	 colorectal	 cancer	 accounts	 for	 approximately	 4500	 deaths	 among	men	
and	 4200	 among	women.	Age-standardized	mortality	 ratio	 increased	 in	 Poland	 from	
6,1/100	000/year	in	1963	to	18,0	in	2000	among	men	and	from	5,0	to	11,0	in	women	in	
the	same	time	(6,	7).
Similar	rising	tendency	has	been	observed	in	other	countries	as	well	(8,	9).	Thus,	one	
of	the	highest	mortality	rates	due	to	colorectal	cancer	has	been	observed	in	the	Czech	
Republic	as	a	result	of	rapid	increase	between	1970–1990	after	which	the	rates	stabilized	
at	the	relatively	high	level.	Otherwise,	in	some	countries	in	the	West	and	North	Europe	
very	slow,	but	consistent	decrease	in	mortality	pattern	has	been	observed.
Colorectal	 cancer	mortality	 trends	 in	 Poland	 are	 similar	 to	 those	 in	 Japan,	where	
mortality	rates	for	men		increased	from	below	10/100	000/year	in	1970	to	about	17.5	in	
1996	and	thereafter	stabilized.	In	Poland,	however,	slight	increase	in	colorectal	cancer	
mortality	in	men	after	1996	has	been	noted.	The	lowest	mortality	rates	are	reported	from	
Africa,	Central	America,	Central	South	and	Eastern	Asia	and	relatively	low	from	Greece.	
However,	in	all	these	regions	steady	rise	of	rates	has	been	reported.
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Regional	variability	of	colorectal	cancer-related	mortality	in	women	and	men	is	simi-
lar.	Mortality	rates	in	men	are	about	50%	higher	than	in	women	with	steadily	increasing	
tendency	observed	worldwide.	 In	Poland,	colorectal	cancer	age-standardized	mortality	
almost	doubled	within	the	past	35	years.	In	the	Czech	Republic,	after	rapid	increase	of	co-
lorectal-cancer	related	mortality	between	1970–1990,	and	a	small	decline	in	1990–1999,	
the	rates	stabilized	and	were	comparable	with	those	highest	in	the	world.	Steady	increase	
has	been	reported	also	from	the	countries	with	relatively	low	mortality	rates	observed	ear-
lier	(e.g.,	Greece,	Thailand).	Moreover,	declining	colorectal	cancer	mortality	patterns	un-
til 2000 observed in the USA and Western Europe reflected growing tendency thereafter.
The	global	burden	of	cancer	in	general	and	also	for	colorectal	cancer	may	be	more	
serious	than	mentioned	above,	since	according	to	Mathers	the	rates	of	the	cancer	mortal-
ity	are	underestimated	(10).
Although	mortality	rates	seem	to	provide	precise	information	because	the	causes	of	
deaths	 are	 accurately	 collected	 and	mortality	 databases	 are	 easily	 available,	 the	 inci-
dence	provides	more	valuable	estimates,	since	it	does	not	depend	on	the	ability	of	the	
health	care	system	to	effectively	cure	the	disease.	
The	Global	Burden	 of	Disease	 2000	project	 showed,	 that	 colorectal	 cancer	 is	 the	
third	most	common	cancer	across	the	world	and	accounts	for	8.9%	of	cancer	cases	(11).	
There	are	more	 than	917	000	new	colorectal	cancers	annually	worldwide,	with	about	
377 000 new cases in Europe, 242 000 in Western Pacific and 160 000 in America. It was 
confirmed that colorectal cancer incidence increases with the level of the development 
in	the	region.	
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In	Poland	in	the	past	40	years	3-fold	increase	in	colorectal	cancer	age-standardized	
incidence	among	women	(from	5.5	 in	1963	to	15.9/100	000/year	 in	2005)	and	4-fold	
among	men	(from	6.2	in	1963	to	27.4/100	000/year	in	2005)	was	observed.	
Cancer of colon and rectum is age-specific. Colorectal cancer incidence rates in Po-
land	rapidly	increase	among	people	after	the	age	of	50	and	stabilize	at	the	age	of	80,	ex-
ceeding	250/100	000/year	for	men	and	150/100	000/year	for	women.	Mortality	rates	are	
reflecting growing tendency throughout the life span, reaching 292.7 colorectal cancer 
deaths/100	000/year	among	men	at	the	age	85	and	over,	and	197.1	deaths/100	000/year	
among	women	in	the	same	age	group.
Measures	(like	cancer	mortality	and	incidence)	presented	above,	despite	being	widely	
used,	have	some	disadvantages.	They	do	not	take	into	account	consequences	of	the	dis-
ease	other	than	death,	like	impairment,	disability	or	handicap.	Therefore,	other	measures,	
like	DALY,	were	created.	DALYs	for	a	disease	are	the	sum	of	the	years	of	life	lost	due	to	
premature	mortality	(YLL)	in	the	population	and	the	years	lost	due	to	disability	(YLD)	
for	incident	cases	of	the	health	condition.	Thus,	the	DALY	is	a	health	gap	measure	that	
extends	the	concept	of	potential	years	of	life	lost	due	to	premature	death	(PYLL)	to	in-
clude	equivalent	years	of	‘healthy’	life	lost	in	conditions	broadly	termed	disability.	One	
DALY	represents	the	loss	of	one	year	of	equivalent	full	health.	
The	global	loss	of	DALY	related	to	colorectal	cancer	is	estimated	as	3	121	000	in	men	
and	2	697	000	in	women.	Since	colorectal	cancer	is	typically	observed	in	the	developed	
communities,	thus	the	majority	of	losses	of	DALYs	is	observed	in	the	developed	(males	
–	1	555	000;	females	–	1	354	000)	and	in	the	low	mortality	developing	countries	(males	
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–	1	120	000;	females	–	1	014	000).	The	estimated	loss	of	DALYs	in	the	European	region	
is	983	000	for	men	and	879	000	for	women.	In	Africa	121	000	loss	of	DALYs	for	men	
and	99	000	for	women	were	registered.	Most	of	the	losses	of	DALYs	are	attributable	
to	premature	deaths.	The	estimated	YLDs	are	only	309	000	for	men	and	301	000	for	
women,	accounting	for	about	10%	of	DALYs.	In	the	high	mortality	developing	countries	
YLDs	are	only	8000	for	men	and	9600	for	women.
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Although	 the	 frequency	of	 colorectal	 cancer	 seems	 to	 be	 similar	 among	men	 and	
women,	the	male/female	pattern	of	colorectal	cancer	mortality	changes	over	time.	Be-
fore	2000	increasing	trends	in	male/female	(M/F)	ratio	were	observed	across	the	world,	
however,	the	degree	of	change	varied	across	countries.	During	the	past	thirty	years	in	
Sweden	the	M/F	ratio	increased	only	by	6%,	in	Italy	by	11%,	but	in	Greece,	Japan	and	
Czech	Republic	 the	change	was	even	 larger,	and	 reached	30%.	 In	Poland	 increase	 in	
M/F	colorectal	cancer	mortality	ratio	was	even	higher	reaching	39%	(from	1,24	to	1,72),	
however,	after	2000	the	decrease	was	observed.	
Probably	 smaller	 progression	 in	 age-adjusted	 colorectal	 cancer	 mortality	 among	
women	is	responsible	for	the	change	in	the	M/F	colorectal	cancer	mortality	ratio.	How-
ever,	this	relationship	was	observed	till	2000,	but	thereafter	age-adjusted	colorectal	can-
cer	mortality	clearly	rose	among	women,	and	stabilized	in	men	allowing	M/F	mortality	
ratio	to	decrease.	It	is	not	clear	what	other	factors	may	be	responsible	for	the	changes.
There	are	a	lot	of	prevention	programs	implemented	across	the	world,	but	increasing	
colorectal cancer mortality is still observed. Up to date it is difficult to estimate whether 
observed trends could be artefactual or whether they reflect growing risk of colorectal 
cancer	across	populations.	The	procedures	related	to	establishing	diagnosis	and	register-
ing cancer cases have improved over time, and being more sensitive may partially influ-
ence observed changes of the rates. On the other hand, growing numbers of the identified 
colorectal	cancer	 risk	 factors	may	be	even	more	plausible.	Genetic	 susceptibility	and	
differences	between	sexes	account	for	the	differences	in	M/F	colorectal	cancer	mortality	
ratio.	These	ambiguities	point	to	the	need	for	the	detailed	studies	in	the	future.
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Although	increasing	trends	in	colorectal	cancer	incidence	and	mortality	are	mostly	
associated	with	 the	known	risk	factors	and	 their	 interactions	with	genetic	susceptibil-
ity,	 the	selection	of	diagnostic	 tools	used	over	 the	past	decades	may	also	have	effect.	
Some of the methods were unavailable fifty or thirty years ago. For example, the use of 
diagnostic	colonoscopy	substantially	increased	the	number	of	performed	polypectomies	
to	remove	colorectal	polyps,	which	might	in	fact	be	precancerous	lesions.	In	this	way,	
the	number	of	diagnostic	colonoscopies	performed	in	a	given	population	may	lower	the	
incidence	rate	of	colorectal	cancer	analyzed	in	future	for	this	particular	group.	Wide	use	
of	screening	tests	shifts	the	time	of	diagnosis	of	colorectal	cancer	to	early	stages	which	
is reflected in the higher incidence rates over this particular time period. 
Colorectal	cancer	may	have	different	origin	and	different	localization	in	the	colon,	
i.e., in caecum, ascendent, transverse, and descendent colon, hepatic or splenic flexures, 
sigmoid	colon	and	rectum.	Over	the	past	30	years	tumours	of	the	right	colon	have	been	
considered more common (12, 13, 14). The interpretation of these findings may be dif-
ficult due to many reasons. First of all, the study samples contained relatively large 
proportion of site unspecified tumours. There is evidence showing that tumours of the 
right	colon	are	over	represented	among	women	in	the	West	Europe	countries	(15).	The	
investigators used different classifications of the left and right sided-tumours, and finally, 
frequency	distributions	presented	for	 the	sub-locations	were	not	age-standardized	and	
not	all	series	were	population	based.
There	 are	 large	 geographical	 differences	 in	 the	mortality	 and	morbidity	 observed	
across	the	World.	The	incidence	of	colorectal	cancer	varies	by	25-fold	between	the	re-
gions	with	the	highest	and	the	lowest	frequency.	The	loss	of	DALYs	also	shows	large	
variations.	Most	of	the	authors	attributed	these	discrepancies	to	diet-related	factors,	as	
responsible	for	up	to	80%	of	colorectal	cancer	cases.	However,	genetic	predisposition,	
environment	and	other	life-style	factors	may	also	play	important	role	in	the	colorectal	
cancer	pathogenesis	and	development.	Up	to	date	there	are	different	opinions	concerning	
etiology,	pathogenesis,	and	genetic	predisposition	in	the	colorectal	cancer,	thus	system-
atic,	collaborative,	international	investigations	are	needed	to	unravel	this	(16).
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